Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AERS(.0053)...accumulated a position.....
Finished accumulating a 1.2+M position in AERS over the last two days at an average under .00485 per share. From an overall fundamental/structural standpoint AERS is not a particularly attractive shell (or quasi-shell). Probably some risk of some type of reorganization (reverse split) at some point, but that is just a guess on my part.
Should be some potential catalysts approaching reasonably soon, and it doesn't appear that many investors are aware of them yet. It appears that a new/former CEO has taken over the company again. Based on the employment timing of the new CEO and his registration of a new website, my guess/hunch is that there will be a change in business direction.
The LinkedIn profile page for former AERS CEO Harold Rounds says he has been the CEO of Aerius International since October 2019......
https://www.linkedin.com/in/harold-rounds-7325ba105/
Harold Rounds registered a website for Sunyani Energy on August 10, 2019.......
https://domainbigdata.com/nj/1YxUofvmNrBM1210BHBDOg
The website for Sunyani went semi-active this morning. It is still under development, but it gives you a description of the business......
ICCO(.01)...accumulated a position......
Finished accumulating a position in ICCO on Friday (currently holding 387K shares at .0092 average). Have been accumulating over the last few months or so. Also still holding a large position in its sister stock (MRDH) for quite a few years. If the CEO starts filing or updating either one of these stocks, things could get a bit interesting. Both of these stocks have shown the ability to move pretty wildly on relatively small volume.
Back in 2017 Anthony Dike (the CEO for ICCO/MRDH) registered two websites related to these companies.....
https://domainbigdata.com/nj/3XGnXHNF5GbT2EiD28ad_R03IsmUmBk-jSeyMj3vDJY
When Adijas posted about the CA SOS filing earlier this year, I started to monitor ICCO a bit more closely. In early July, the Vasocor website went active. A couple/few weeks later the corporate website for ICCO underwent a redesign. That redesign was pretty significant in my mind for two reasons. Aside from replacing a very old/stagnant looking website with something that looks a bit more modern, for the first time the website actually contained some information about its NASA technology license agreements (see the White Papers section of the site).
For quite a few years Anthony Dike and his company have had license agreements in place with NASA for microwave-related technology (wound closure, artery treatments, etc). Whenever these licenses come up for expiration, they keep getting renewed. Use a "control F" search for "meridian" to find the licenses.....
https://www.nasa.gov/sites/default/files/atoms/files/house_approps_action_domestic_nonfed_saas_active_as_of_6-30-2019.pdf
One thing I found particularly interesting in that White Papers section is the "hyperspectral imaging technology". That was a technology I was unaware they were involved with until it showed up on the website update. I don't know if there is any connection between the two things, but I do find it somewhat interesting that Dike changed the name of a MRDH subsidary to "SpectraCare Holdings" back in mid-2018......
https://www.sos.state.co.us/biz/ViewImage.do?masterFileId=20051011296&fileId=20181453266
Most investors are probably completely unaware of these licenses/technologies. This is the kind of thing that could move these stocks if the website changes/updates are any indication that Dike is planning increased corporate activity in ICCO/MRDH.
PRFC...Bridgerock website is now active......
Added another 2M shares to my position this morning at .0048 (currently holding a 4.5+M position at an .0051 average). Some type of corporate activity should be getting closer I would think. I will be somewhat disappointed if this stock doesn't see prices above ten cents at some point.
The Bridgerock Technologies website went active either yesterday or over the weekend, and it has been actively changing/updating since I last looked at it yesterday morning.....
https://www.bridgerocktech.com/
zenvesting...EMPM...position, structure, etc.....
ANAS(.006)...accumulated a position.....
Finished accumulating a position in the ANAS shell over the last couple of weeks (1.1+M shares at .0048 average). Extremely high-risk, but the risk/reward just looked too enticing for me to pass up.
I figure I am either going to lose my entire investment here, or this could produce some huge upside from these sub-penny levels.
The previous CEO (Matthew Briggs) sold off basically all of the assets/debts of the old business a few years ago. He moved the state of incorporation to Wyoming, and handed over control of the shell to Sara Dascott (a woman from Florida). I have no idea what (if anything) Dascott has done with the shell, but there could be a chance this is still a reasonably clean shell. If that share structure is still anywhere close to the 22.2M reported back in 2015, the valuation here would be extremely attractive.
Some reasons why I think this could be interesting timing for entry/accumulation: 1) The deadline for a simple reinstatement of ANAS on the Wyoming SOS is coming up in January 2020. 2) With the SEC wanting to escalate its war on shells, reverse mergers, and dark/defunct stocks, I'm semi-expecting we will be seeing increased levels of RM activity, changes in control, custodian activity (both hostile and friendly) etc, etc, in the coming months as people try to salvage as many OTC stocks as they can before new regulations fall into place.
But, again, the risk level here is very high. Could be a flip-of-the-coin kind of investment.
VODG...sold my position.....
XNYH(.025)...HYB Holding(s)......
PRFC(.021)...archived site provides additional information......
Significantly increased my position in PRFC while it was still at the sub-penny level (currently holding 2.3+M shares at .00486). If/when additional corporate activity occurs (filings/updates, etc), I think PRFC has a decent chance for major upside.
If you look at the January 31, 2018 archived Epcylon website, you will find two shareholder updates (one from August 2016, and another from August 2017). It appears neither of these items received much investor attention at the time they were issued/posted, but I find them quite interesting/significant now as it appears that some type of corporate activity at PRFC might be approaching. Here are some excerpts........
Letter to Shareholders (8/4/2016):
MTRI(.015)...GDS Group website is now active.....
Increased my position in MTRI last week by picking up about 250K shares at one cent. Based on some recent website activity, I figured it might be a good idea to pick up some additional shares just in case some type of corporate activity is approaching and/or there is another nice tradeable move in the stock. This penny/sub-penny price area usually seems to offer a pretty good area for entry/accumulation.
Asian reverse mergers are often extremely difficult to research/analyze. The language differences usually make websites and press releases confusing/awkward/clumsy/wierd, so you sometimes just have to do your best guessing at what is going on. My observations/viewpoints on MTRI could be completely different from other investors/traders. This is definitely a high-risk investment.
There is a goal/desire of the new management/directors to have this company trading on the Nasdaq main board (based on comments/statements I have seen on their Facebook pages), so I wouldn't be surprised at all if there is a reverse split at some point. So invest accordingly.
On March 4, MTRI issued that press release about the appointment of some new officers/directors. From March through May or so, every once in awhile I would do Google searches on snippets of their biographies or image search their photos. Other than their obvious connection to the water device company/business, nothing unusual would show up. When I image searched one of the guy's photo last week, this website (which was registered in January 2019) suddenly showed up.....
http://gds-hd.com/
This site clearly has a connection to MTRI.....
1) Image #5 in the carousel of images on the home page has MTRI's CIK number: US Public Listed Company: CIK.0001391883
2) Mission statement: Promoting BULLZI holding to public listed in main board NASDAQ market within two years.
3) Photos and biographies of all three of the MTRI officer/directors mentioned in that March press release can be found in the "Our Team" section of the site.
Now, I don't know whether MTRI owns all of GDS Group, or just the resort division/business of GDS. Just to be on the conservative side I am assuming it is the resort side of the company. If that is the case (and based on information that can be found on the website and the director's Facebook pages), then MTRI owns a resort valued at $2.4M, is developing a 69-acre area with a planned total investment of $72-120M, and planned acquisitions of another resort, another resort development area, and an island in Indonesia.......
1)
XNYH(.02)...accumulated a position.....
Finished accumulating a large position in the XNYH shell over the last 7 months or so (974k shares at a .01483 average). I think it is worth swinging-for-the-fence on this shell.
Based on the reasonably healthy condition of the company at the time it stopped its SEC filing obligations in 2012, and there was no change in the share structure reflected in the November 2018 OTC Markets update, I think there is a decent chance that XNYH is a relatively clean shell.
If the share structure today is still relatively close to the November update (19.5M outstanding, 3.2M float), this shell looks extremely attractive from an overall structural/valuation perspective.
PRFC(.0045)...accumulated a position....
Accumulated a 1.8+M share position in PRFC at a .00378 average. Risk/reward at these sub-.005 levels looks pretty interesting to me. The recent activity involving the Nevada filings and website registration(s) all seem to suggest that some type of corporate activity is approaching. I figure it might be a good idea to be pre-positioned ahead of any additional activity/announcements.
Nevada filings: On May 8, 2019, the authorized share count was increased from 300M to 425M. There also was an amendment/designation of the 15M preferred share shares.
https://www.nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=nl8z1x%252bFcOtkpsLiuhPLrA%253d%253d&CorpName=EPCYLON+TECHNOLOGIES%2c+INC.
Bridgerock Technologies website: When the Bridgerock website registration was updated in January 2019, Epcylon Technologies became the new registrant. Before PRFC went dark, it was known that PRFC was interested in acquiring Bridgerock.
https://domainbigdata.com/bridgerocktech.com
Epcylon has registered other websites: Epcylon Technologies has registered some other websites in late May and early June. Two of the sites are probably related to crypto/Forex trading, and the other two sites are for an asset management company owned/managed by James K Lau.......
CLCL(.009)...possible confidentiality agreements with major companies......
I trimmed off some of my CLCL position around the .025-.03 area on this recent surge, but still maintain a nice position. The stock is extremely risky (and the CEO Norman Kaplan will make you want to pull your hair out), but it might be worth monitoring the stock closely for the remainder of 2019. Based on the shareholder letter that Kaplan posted on Facebook last night, he is expecting that CLCL will have some material developments this year.
Now, take the following for what it is worth: When the shareholder letter was first posted last night, it contained a sentence that Kaplan included to help explain why he is limited in what he can say about what is going on at the company. To paraphrase: "Some of our situations involve confidentiality agreements with multi-billion dollar companies."
I am almost 100% certain this statement (paraphrased) was in the letter, because it caused me to go back and reread the letter at least three or four times. When I got up this morning, that statement was (and still is) missing. So I am assuming that Kaplan went back and edited the letter.
It is possible that very few investors are actually aware of that statement. It certainly got my attention, especially when you combine it with another statement that still remains in the letter.....
EMPM(.0164)...possible RM with Saean......
Based on the Nevada filings of EMPM and "Saean Inc", it would appear to me that Saean would seem to be the most likely RM target for the EMPM shell. Saean is an electric vehicle company in South Korea, extablished in 2013.
Jung Lee (the new President of EMPM) filed a Nevada registration for Saean in October 2018. Names of all three of the new officers listed in the EMPM Nevada filing can be found in an article regarding the establishment of Saean's headquarters in the United States. Also, Saean is the cover story in the February 2019 issue of CEO Economics, and that article states that Jung Lee expects to bring Saean public in the US market during the first half of 2019.
Nevada filings......
EMPM: https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=V9M0c1l4F0T2%252f20MXKYx7Q%253d%253d&nt7=0
Saean: https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=NDnsBFmNDOpdhKC%252fMjdN6g%253d%253d&nt7=0
May 16, 2019 article about the establishment of Saean's US headquarters during 2018......
ECGI(.0064)...10-K filed on June 3.....
ECGI(.0085)...new management, website registered......
Recent events surrounding the ECGI shell might suggest that finally something of significance might be drawing closer. Whether this ultimately turns out positive/negative for the retail shareholders remains to be seen, but at least there appears to be some glimmer of hope/activity now.
It has gone largely unnoticed, but Adam Sexton has taken management control of the ECGI shell according to the May 17 update on the NV SOS. Sexton is a pretty well-connected individual in the business world.......
https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=kYOmkJYc62w2Hlxv%252fXZGzw%253d%253d&nt7=0
Also, last week a new website link showed up on the OTC Markets profile page. The website was registered on May 9.......
https://ecgiholdings.com/
https://domainbigdata.com/ecgiholdings.com
Some information/links on Adam Sexton (Note: he was a former CEO and Board member of Wealthcraft, but resigned earlier this year)......
https://www.linkedin.com/in/sextonadam/
https://twitter.com/Adamski12
https://www.wealthcraftcapital.com/team
XNYH(.015)...accumulated a position.....
Accumulated an 840K position in the XNYH shell over the last 6 months at an average of .0142 per share. Purchased shares in the .008 to .0199 range. High risk, like any other shell, but these prices under 2 cents look extremely attractive to me.
When I went through the last quarterly filing (2011), I didn't notice any items that would overly concern me. So I think there is a decent chance that XNYH is a relatively clean shell. Last share structure update on OTC Markets (November 2018) showed 19.5M shares outstanding, with a float of 3.2M shares. No change in the share count since the last quarterly filing.
FAVO(.202)...Napolitano's LinkedIn post from yesterday.....
VBVT(.15)...RM completion expected May 31.....
VBVT shell is getting closer to completion of the reverse merger with Firetainment (now expected to occur in about 5 weeks, May 31). I'm holding a 35K position at a .235 average. Should be pretty interesting to see exactly how everything plays out, (for example, business development/expansion, any additional/synergistic acquisitions, conversions of the debt, any third-party equity investment, etc, etc.) but I continue to believe I will get an extremely nice return on my investment here.
From the March 28 8-K, the new share exchange agreement has reduced the number of shares to be issued in the RM (original agreement was for 8M -- the new agreement is for 5M). Share structure of the VBVT shell as of March 12: 1.2M outstanding, 296K unrestricted......
LWLW(2.00)...subsequent events section of 10-K.....
I'm still holding a 6,350 share position in the LWLW shell at a $2 average. Structure/valuation of this shell continues to look interesting/attractive. LWLW might be getting somewhat closer to some type of RM activity, based on the subsequent events section of today's 10-K filing......
Lou Ferrigno...article, testimonial.....
Cayman Compass article.....
rstar...Seng Y Kok, Global Network Capital.....
Bahamas clinical trial approval.....
Lack of filing urgency is alarming.....
JonesBur...results timetable, filing delinquency.....
VODG(.175)...possible R&D development.....
Picked up a few more shares a couple of weeks ago for a possible trading pop/spike soon (see link below). This 20-cent area continues to look interesting to me as we wait for the FY 2018 press release. Just have a hunch/feeling there is going to be a pretty big tradeable move in the share price shortly after that PR is issued.
By the way, the stock I mentioned at the end of the below post is now trading at a fully-diluted valuation of $656M (7.29B shares x 9 cents/shr).....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145931810
One thing I definitely want to see in this press release is a detailed/positive update and commentary on the filing delinquency situation. I know this sounds like a broken record, but I can't stress enough how important this is. I'm sure I am not the only investor who will be making adjustments to my position size in the first half of 2019 if management doesn't convey a sense of urgency regarding the filing delinquency.
Here is one thing that could turn into an interesting catalyst: It is possible (and I stress the word "possible") that VODG is currently modifying its stem cells for use in spinal fluid. The husband of one of the Vitro Biopharma patients in New Zealand made an update post on January 7 (2 weeks ago) regarding some future developments in her treatment for 2019.
He does not mention if these new stem cells will be coming from VODG or if another company is involved. If it turns out that these new cells are in fact coming from Vitro Biopharma, things could get extremely interesting here........
BESE(.0065)...management change on NVSOS.....
VBVT(.07)...shell debt acquired by Firetainment officer.....
VODG(.208)...expecting FY 2018 results soon.....
Extremely high-risk investment because of the filing delinquency. Having said that, I picked up some more shares at .205 last week for possible trading opportunities in the near future.
I'm semi-expecting to see the company release a FY 2018 press release soon (perhaps this week). I think there is a reasonably decent chance of seeing increased interest/volume in the stock during 2019 and maybe some nice tradeable moves in the share price.
VODG should be entering/continuing a period of growth in the stem cell therapy part of its business. The sales director that the company recently hired looks impressive and should be helpful in the marketing of all products/facets of the business. VODG registered its facility with the FDA for manufacturing/packaging of cosmetic products in mid-December, so it looks like the upcoming cosmetic product is on schedule for introduction in 2019. The CEO recently started updating his personal/business social media presence after about 3 years of silence.
Somewhat interesting to note in light of the recent reverse merger between AVOZ and Nurish.me LLC (which has a cognitive/immune supplement line): VODG has a cognitive/immune supplement line called NutraVivo. My hunch is that the company (and the new sales director) will probably try to increase market awareness of this product this year. Although it is not fair to compare VODG to AVOZ (which has a more established market presence) in this particular product area, it is interesting to note that AVOZ is currently trading at a fully-diluted market cap around $300M.
RNGC(.0048)...accumulated a position.....
Finished accumulating a good-sized position in the RNGC shell over the last couple of trading days. Extremely high-risk investment because of the filing delinquency, but hopefully the new management will move quickly to resolve that issue following the late December reinstatement.
This .004-.0051 price area looks reasonably attractive to me for entry/accumulation. The company/shell looked relatively clean (debt, overall share structure, etc.) around the time of its last quarterly filings (2013), so with some luck there could be some decent upside here.
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=QQUBGr6sW3piylHhN4TLYA%253d%253d&nt7=0
BESE(.01)...added to my position.....
VODG(.22)...next 4 months should be interesting......
The next 4 months for VODG could turn out to be pretty interesting. Assuming the company maintains its schedule for financial performance press releases, we should be seeing at least two PRs in that time frame (FY 2018 and Q1 2019).
Given how informative its PRs have become, each of those press releases could be catalysts for tradeable spikes in the share price or sustained moves into higher trading ranges.
FY 2018 revenue should be well over $500k, and the quarter-over-quarter comparisons in early 2019 should look favorable. VODG has come a long way from the days when a $5-10K quarter was considered good.
I think it is a good idea to go back and read that Q3 press release again (see post above). VODG is telegraphing that business operations (on a number of fronts) are about to ramp up significantly in this coming year. That information regarding IRB-activity in foreign countries is potentially huge, especially when you consider how VODG's revenue to date has been positively influenced by exposure to basically just two clinics (New Zealand, Cayman Island).
https://vitrobiopharma.com/vitro-biopharma-3rd-quarter-ended-july-31st-2018-financial-results-of-operations/
m0n...BESE share structure......
BESE(.0081)...RM activity should be relatively close......
ECGI(.0038)...new CEO on NVSOS......
It has gone largely unnoticed, but it is somewhat interesting to note that ECGI changed its Registered Agent and filed its annual list on November 14. A new Ceo is now in charge (Donald Bell replaces Gary Blom).....
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=kYOmkJYc62w2Hlxv%252fXZGzw%253d%253d
ECGI is easily the most frustrating/irritating investment I have ever made. The company was developing an ambulatory cardiac monitoring device called NowCardio (which has now been rebranded as "Liba3"). When one of the previous management/legal teams decided to acquire another product/technology (breast cancer detection area), the agreement they signed needlessly exposed ECGI to a large financial risk and this likely ended up being the ultimate downfall for the company. The management/legal team could have protected the company with just a simple sentence/paragraph/clause in the agreement, and none of the ensuing problems would have occurred.
This is the technology/product that would still be under the ECGI umbrella if it were not for that ill-advised agreement......
https://nationalcardiac.com/
Adding to the frustration from a retail shareholder perspective: To the best of my knowledge neither of the previous two CEOs (John Bentivoglio and Gary Blom) have ever provided any explanation/update as what exactly happened to the company and the current status of ECGI. Shareholders were left completely in the dark. So I am working under the assumption that ECGI is probably a shell at this point, and quite possibly a relatively "messy" looking shell for a number/variety of reasons.
The timing of the change in CEO is rather interesting. The two previous CEOs (and the company) appear to still be involved in some type of legal dispute.....
https://www.pacermonitor.com/public/case/23865032/Bentivoglio_et_al_v_Event_Cardio_Group_Inc_et_al
tjvs...revenue, May Kok......
tjvs...split, Focus Point....
BLLZ(.0055)...management change on NVSOS.....
Picked up another nice 100K block of shares on Tuesday at .005, in anticipation of seeing a management change reflected in the NVSOS annual list due on 10/31/2018.
It's very encouraging to see the filing was made on time, and BLLZ is now officially under different management. Still crossing my fingers and hoping things will look good from a structural standpoint. But even in situations where the structure/marketcap may not be ideal, sometimes these Asian reverse mergers can undergo some pretty wild/crazy/explosive moves in share price.
Based on the limited information in the July press release on the BLLZ website, I am assuming the new company/business is modeled to a large extent after Focus Point, which is the leading optical company in Malaysia.....
https://www.focus-point.com/about-us/
http://focuspoint.listedcompany.com/misc/ar2017.pdf
NVSOS management change.....
https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=neHhP9zJ7Wpkug6Gv1ksZg%253d%253d&nt7=0
CAPV(.003)...picked up a position.....
Keith Burge...Sales/Marketing Director for VODG......
The addition of Keith Burge as the Sales/Marketing Director is another good sign that business operations should be ramping up significantly in the upcoming year(s). Burge would also be an extremely interesting option for a future VODG CEO if Jim Musick ever decided to step aside.
Burge's most recent company that he co-founded is Confadent (dental gum product/tech). You can see him in this segment of Modern Living with kathy ireland......
https://confadent.com/blogs/news/modern-living-with-kathy-ireland
Keith Burge background information.....
https://www.bencolorado.org/keith-burge/
VODG October 23 press release......